Effect of drug release rate on bioavailability of different aspirin tablets

International Journal of Pharmaceutics

Volumn 133, Issue 1-2, 1996, Pages 65-70

  Torrado, S ^a   Cadorniga, R ^a   Torrado, J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Acetylsalicylic acid; Bioavailability; Dissolution rate; Eudragit; Sustained release

Indexed keywords

ACETYLSALICYLIC ACID; EUDRAGIT; EUDRAGIT RS; MICROCRYSTALLINE CELLULOSE;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISSOLUTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RELEASE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; TABLET; VOLUNTEER;

EID: 0029953574     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04411-6     Document Type: Article

References (11)

1. Baveja, S.K., Ranga Rao, K.V. and Padmalatha, D., Zero-order release hydrophilic matrix tablets of β-adenergic blockers. Int. J. Pharm., 39 (1987) 39-45.
2. Fernandez-Arevalo, M., Holgado-Villafuerte, M.A., Gines-Dorado, J.M. and Rabasco-Alvarez, A.M., Effects of different fillers and wetting liquids on the dissolution behavior of carteolol hydrochloride controlled release inert matrix tablets. Int. J. Pharm., 95 (1993) 117-125.
3. Ford, J.L., Rubinstein, M.H., Mc Caul, F., Hogan, I.E. and Edgar, P.J., Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethyl-cellulose matrix tablets. Int. J. Pharm., 40 (1987) 223-234.
4. Gadalla, M.A.F., Ismail, A.A. and Abd El-Hameed, M.H., In vivo evaluation of different types of commercial aspirin tablets. Drug Dev. Ind. Pharm., 15 (1989) 447-472.
5. Jenquin, M.R. and McGinity, J.W., Characterization of acrylic resin matrix films and mechanisms of drug-polymer interations. Int. J. Pharm., 101 (1994) 23-34.
6. Kislalioglu, M.A., Khan, M.A., Blount, C., Goettsch, R.W. and Bolton, S., Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates. J. Pharm. Sci., 80 (1991) 799-804.
7. Padmalatha, K.D., Ranga Rao K.V., Baveja, S., Marc, F. and Marc, R., Zero-order release formulation of oxprenolol hydrocloride with swelling and erosion control. Pharma Res., 6 313-317 (1989).
8. Reza, A.F. and Ritschel, W.A., Multiple-Layer, Direct-Compression, Controlled-Release System: In Vitro and In Vivo Evaluation. J. Pharm. Sci., 87 (1993) 750-754.
9. Soons, P.A., De Boer, A.G., Van Brummelen, P. and Breimer, D.D., Oral absortion profile of nitrendipine in healthy subjects: a kinetic and dynamic study. Br. J. Clin. Pharmacol., 27 (1989) 179-189.
10. Torrado, S., Torrado, S. and Cadorniga, R., Comparison of assay methods by second-derivative spectroscopy, colorimetry and fluorescence spectroscopy of salicylic acid in aspirin preparations with a high-performance liquid chromatographic method. J. Pharm. and Biomed. Anal., 12 (1994) 383-387.
11. Wingstrand, K., Abrahamsson, B. and Edgar, B., Bioavailability from felodipine extended-release tablets with different dissolution properties. Int. J. Pharm., 60 (1990) 151-156.